Sex: M
Vaccine: DTP, MMR, DTPHIB, HIBV
Symptoms: Dermatitis atopic, Drug toxicity, Encephalopathy, Epistaxis, Eructation
Clinical narrative: Information has been received regarding a case in litigation concerning a minor male pt who was exposed to high levels of mercury from thimerosal through exposure to unspecified products. In additional, the pt was exposed to mercury from continually inhaling and ingesting industry mercury emissions from fossil fuel driven power plants. The mercury included in thimerosal laden products and power plant emissions together caused the pt to suffer from serious and permanent neurological injuries. The pt was exposed to airborne mercury vapor and mercury through food chain. The exposure to airborne mercury in the environment through inhalation, the food chain, and other sources contributed to the cumulative mercury toxicity and was a substantial factor in causing his neurological damage. it was noted that the pt had a heightened vulnerability to suffer neurological injuries from industrial mercury as a direct result of thimerosal exposure. As a direct and proximate cause of the toxic mercury exposure to  the pt, minor male was caused to suffer serious and permanent neurological damage which included past and future mental, intellectual, development and neurological incapacity and associated learning disabilities, disorders and impairments. Upon internal review, serious and permanent neurological damage injuries which include past and future mental, intellectual, developmental and neurological incapacity and associated learning disabilities, disorders and impairments and cumulative mercury toxicity were considered to be other important medical events (OMIC). Follow up information has been received from medical records concerning a male with drug hypersensitivity to pertussis and a history of eye discharged, rhinorrhoea, gas, restlessness, constipation, nasal stuffiness, croup and lingual frenectomy. The child has a family history of the father with delayed speech and articulation problems. On 7/7/1995, the child was vaccinated with MMR II (lot number 615019/0205B, exp 2/9/1997) SQ in the right thigh. Concomitant therapy included DPT (lot 369908), DT (5F71080 exp 6/1/1997), polio virus vaccine (lot number 699L5), Hib vaccine unspecified IM lot number 4L61040 exp 11/28/1996, Engerix B (lot 131582), on 3/21/1997 varicella vaccine (lot 00836 exp 7/98) SQ on right, and polio virus vaccine oral. In development, the pt sat up on his own at 7 months, stood alone at 9 months, walked alone at 10 months. At 18 months the pt had a social regression with decreased eye contact and abnormal interaction. At approx 2 years of age the pt underwent a regression in his language to no words approx 3 yrs 3 months of age. It was noted that the child rode a tricycle alone at 4 years of age. On 5/19/1997 the pt was diagnosed with autistic encephalopathy. The child was enrolled in an autistic program and has been successful in adapting to his self contained and regular education program. It was noted that the child is potty trained in the 1999-2000 school year summary. It was also noted in a neurodevelopmental cognitive disorder clinic note on 4/20/2000, that the child has made significant gains through applied behavior analysis, and that the child is using language to communicate his wants and needs, and his vocabulary has become more extensive. Upon internal review, autistic encephalopathy was considered an other important medical event (OMIC). Follow up information obtained on 9/13/2006 contained the following adverse experienced enlarged adenoids 5/3/96, allergic to amoxicillin, acute croup attack, purulent rhinitis and sinusitis 1/26/97, excessive cerumen bilaterally 4/25/97, croup and early sinusitis 12/23/97, dehydration and croup 1/12/98, pharyngitis 5/17*99, excision of nevus left post auricular area and hayfever 5/20/99, wart under toenail 8/13/99, hyperactivity, trouble sleeping and acting hyper and difficult 9/3/99, URI 12/9/1999, pharyngitis 2/24/00, recurrent rhino sinusitis, perennial allergic rhinitis and epistaxis 4/20/00, strep throat 5/11/00, rash on face questionably related to melatonin 8/24/00, vomiting, fever and abdominal pain 10/14/00, vomiting 10/16/00, sinusitis 11/3/00, vomiting 10/16/00, sinusitis 11/3/00, persistent fever, persistent vomiting and dehydration 11/12/00, strep tonsillitis 11/16/01, nasal drainage and nasal stuffiness 12/17/02, allergic rhinitis and sinusitis 3/13/03, strep tonsillitis 11/18/03, strep pharyngitis 12/05/03, worsening allergies 4/21/05, mild atopic dermatitis on buttocks 7/19/06. Additional information is expected. All available medical records are attached as further documentation of the pts experience.